Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | BRWD1 |
| Upstream (Parents) |
|---|
| (<<) INADL → BRWD1 |
| (<<) AVL9 → BRWD1 |
| (<<) C17orf86 → BRWD1 |
| (<<) TACC3 → BRWD1 |
| (<<) ZFYVE9 → BRWD1 |
| Downstream (Children) |
|---|
| BRWD1 → ZNF225 (>>) |
| BRWD1 → ESRRA (>>) |
| BRWD1 → C12orf39 (>>) |
| BRWD1 → VEZT (>>) |
| BRWD1 → ITGA8 (>>) |
| BRWD1 → TAAR2 (>>) |
| BRWD1 → ANO2 (>>) |
| BRWD1 → TMEFF1 (>>) |
| BRWD1 → ZNF639 (>>) |
| BRWD1 → ASPH (>>) |
| BRWD1 → MYOZ3 (>>) |
| BRWD1 → RCVRN (>>) |
| BRWD1 → KIF5A (>>) |
| BRWD1 → PKNOX1 (>>) |
| BRWD1 → ITSN2 (>>) |
| BRWD1 → CDC27 (>>) |
| BRWD1 → MAST1 (>>) |
| BRWD1 → CYLD (>>) |
| BRWD1 → HNRNPA3P1 (>>) |
| BRWD1 → MLLT10 (>>) |
| BRWD1 → PRY2///PRY (>>) |
| BRWD1 → ZFYVE9 (>>) |
| BRWD1 → MTM1 (>>) |
